sanofi buys us haemophilia treatment firm
Last Updated : GMT 06:41:18
Arab Today, arab today
Arab Today, arab today

for $11.6 bn

Sanofi buys US haemophilia treatment firm

Arab Today, arab today

Arab Today, arab today Sanofi buys US haemophilia treatment firm

France's Sanofi is to buy Bioverativ.
Paris - Arab Today

French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for haemophilia and rare blood disorders, for $11.6 billion.

Sanofi's chief executive Olivier Brandicourt said the acquisition "enhances its presence in specialty care and leadership in rare diseases... and creates a platform for growth in other rare blood disorders."

The purchase should also translate into a boost in profits per share beginning this year, rising to a gain of up to 5 percent in 2019, Sanofi said in a statement.

Bioverativ has latest-generation treatments for haemophilia, a disorder where blood does not clot properly to stop bleeding.

The haemophilia drugs market is "the largest market in rare diseases", worth around $10 billion per year and projected to grow by seven percent annually over the next five years, Brandicourt said in an audio conference with analysts.

He said he harboured a "strong admiration" for Bioverativ, which is a leader in the field with two drugs, Eloctate and Alprolix, already in the market and estimated overall sales of $1.2 billion in 2017.

Sanofi said it would be able to help Bioverativ with the research it has underway on the development of other haemophilia treatments, as well as for other rare diseases.

The agreement to purchase all of Bioverativ's outstanding shares for $105 each in cash represents a premium of 64 percent from the closing price on Friday, Sanofi said.

The operation is to start in February and close three months later, Brandicourt said.

But investors were not convinced, sending Sanofi's shares sharply lower on the Paris stock exchange as they wondered about the wisdom of putting so much money on the table.

The deal "looks logical, but expensive", with only modest potential to drive growth in the medium term, judged analysts at the Jefferies firm.

Furthermore, Sanofi may run into competition concerns from regulators with the takeover, they said.

The French firm said it would use funds on hand and borrow to finance the acquisition of Bioverativ.

But although pricey, the acquisition will still leave Sanofi with enough financial firepower to go after other acquisition targets, Jefferies said. One such target could be Pfizer's consumer healthcare business, they said.

The purchase of Bioverativ is the largest Sanofi has made since it acquired US biotech firm Genzyme for $20 billion in April 2011.

The French group failed in its 2016 bid to take over US cancer drugmaker Medivation which instead went to Pfizer.

Sanofi shares were 4.2 percent lower at 69.89 euros in late afternoon trading Monday, vastly underperforming the benchmark CAC 40 index in Paris which was up 0.2 percent.

 

Source: AFP

arabstoday
arabstoday

GMT 03:09 2018 Sunday ,21 January

Second face transplant for Frenchman

GMT 02:42 2018 Thursday ,18 January

Suppressing a sneeze can be dangerous

GMT 05:29 2018 Tuesday ,16 January

Lactalis feels heat as families rebuff

GMT 03:51 2018 Saturday ,13 January

France laments 'dysfunction'

GMT 02:30 2018 Thursday ,11 January

Human muscle tissue grown
Arab Today, arab today
Arab Today, arab today

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



Arab Today, arab today
Arab Today, arab today Skincare PR Performance Full Year 2017

GMT 10:35 2018 Monday ,22 January

Skincare PR Performance Full Year 2017
Arab Today, arab today New hunt for flight MH370 gets under way

GMT 02:36 2018 Wednesday ,24 January

New hunt for flight MH370 gets under way
Arab Today, arab today Modern colorful bedroom renovation

GMT 11:23 2017 Thursday ,21 December

Modern colorful bedroom renovation
Arab Today, arab today France sanctions businesses linked

GMT 01:58 2018 Wednesday ,24 January

France sanctions businesses linked
Arab Today, arab today Turkey detains dozens more

GMT 02:09 2018 Wednesday ,24 January

Turkey detains dozens more
Arab Today, arab today The Rake announces editorial updates

GMT 12:19 2018 Tuesday ,16 January

The Rake announces editorial updates
Arab Today, arab today Europe brings on charm and blue skies

GMT 06:12 2018 Tuesday ,23 January

Europe brings on charm and blue skies
Arab Today, arab today For the Variety of Interior Design Styles

GMT 11:14 2017 Tuesday ,19 December

For the Variety of Interior Design Styles
Arab Today, arab today Puigdemont candidate for Catalan president

GMT 05:31 2018 Tuesday ,23 January

Puigdemont candidate for Catalan president
Arab Today, arab today Amazon to open first cashierless shop

GMT 05:52 2018 Tuesday ,23 January

Amazon to open first cashierless shop

GMT 22:38 2018 Tuesday ,23 January

Bahrain Press headlines

GMT 20:34 2018 Saturday ,20 January

Bahrain press headlines

GMT 07:22 2017 Thursday ,23 November

Zimbabwe's next leader heads home after Mugabe exit

GMT 07:23 2017 Thursday ,23 November

Zimbabwe's next leader heads home after Mugabe exit

GMT 14:33 2017 Tuesday ,19 December

German business morale eases back from record high

GMT 13:36 2017 Friday ,22 December

Iraqi troops killed six ISIS militants in Mousl

GMT 12:32 2017 Tuesday ,19 December

UK weather: The latest Sky News forecast

GMT 12:33 2017 Friday ,22 December

Yara denies presenting new talk show

GMT 01:00 2017 Wednesday ,20 December

Saudi and Russia expnad food integration

GMT 04:53 2017 Tuesday ,19 December

Egypt’s government signs agreement with Switzerland

GMT 04:27 2017 Tuesday ,19 December

Tensions dominate the Iranian parliament amid fears

GMT 11:35 2017 Monday ,18 December

Putin appreciates U.S intelligence cooperation

GMT 08:05 2017 Monday ,18 December

Mona Zaki reveals details of her new show

GMT 16:25 2016 Thursday ,22 December

Italian bank Monte Paschi edges closer to state bailout

GMT 07:16 2017 Sunday ,17 December

Yasmine Underlines importance of Fatimid Cairo

GMT 17:32 2017 Sunday ,17 December

Polls open in Chilean presidential election

GMT 09:12 2017 Friday ,17 November

Gleam Futures represents Grace Beverley

GMT 06:03 2014 Wednesday ,09 April

Please .. Let Gaza breathe!

GMT 06:00 2017 Sunday ,29 October

Childrenswear brand Once appoints Dyelog

GMT 04:18 2017 Sunday ,26 November

Bella magazine appoints celebrity writer

GMT 16:33 2014 Thursday ,13 November

Al-Ehtimam Bil Aakhareen

GMT 03:34 2017 Sunday ,05 November

Needle & Thread relocates press office
Arab Today, arab today
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube
arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday